Calyxt to Present at the H.C. Wainwright BioConnect Virtual Conference

ROSEVILLE, Minn., Jan. 4, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company today announced that a presentation given by management at the H.C Wainwright BioConnect Conference will be available for viewing online on Monday, January 10, 2022 at 7:00 a.m. ET. The conference will be held in a virtual meeting format.

H.C. Wainwright BioConnect Conference
Date: Monday, January 10, 2022
Time: 7:00 a.m. ET (4:00 a.m. PT)

To schedule a meeting with management, please reach out to

The presentation will be available for viewing and replay from the Investors section of Calyxt's website at

About Calyxt:
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit

PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.


Calyxt Media Contact:
David Rosen/John Garabo/Michael Barron
Argot Partners
(212) 600-1902

Calyxt Investor Relations Contact:
Sherri Spear/Cameron Willis
Argot Partners
(212) 600-1902

Calyxt Business Development Contact:
Sarah Reiter
Calyxt, Inc.
(612) 427-7881

Cision View original content to download multimedia:

SOURCE Calyxt, Inc.